138 related articles for article (PubMed ID: 1702812)
21. Release of histamine and tryptase in vivo after prolonged cutaneous challenge with allergen in humans.
Shalit M; Schwartz LB; Golzar N; vonAllman C; Valenzano M; Fleekop P; Atkins PC; Zweiman B
J Immunol; 1988 Aug; 141(3):821-6. PubMed ID: 2456334
[TBL] [Abstract][Full Text] [Related]
22. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
de Paulis A; Cirillo R; Ciccarelli A; Condorelli M; Marone G
J Immunol; 1991 Apr; 146(7):2374-81. PubMed ID: 1706398
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical detection of human basophils in late-phase skin reactions.
Irani AM; Huang C; Xia HZ; Kepley C; Nafie A; Fouda ED; Craig S; Zweiman B; Schwartz LB
J Allergy Clin Immunol; 1998 Mar; 101(3):354-62. PubMed ID: 9525452
[TBL] [Abstract][Full Text] [Related]
24. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge.
Charlesworth EN; Massey WA; Kagey-Sobotka A; Norman PS; Lichtenstein LM
J Pharmacol Exp Ther; 1992 Sep; 262(3):964-70. PubMed ID: 1382132
[TBL] [Abstract][Full Text] [Related]
25. Selective inhibition of the cutaneous late but not immediate allergic response to antigens by misoprostol, a PGE analog. Results of a double-blind, placebo-controlled randomized study.
Alam R; Dejarnatt A; Stafford S; Forsythe PA; Kumar D; Grant JA
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1066-70. PubMed ID: 8214926
[TBL] [Abstract][Full Text] [Related]
26. RANTES induces nasal mucosal inflammation rich in eosinophils, basophils, and lymphocytes in vivo.
Kuna P; Alam R; Ruta U; Gorski P
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):873-9. PubMed ID: 9517605
[TBL] [Abstract][Full Text] [Related]
27. The effect of terfenadine on the immediate and late-phase reactions mediated by immunoglobulin E.
de Weck AL; Derer T; Bischoff SC; Takafuji S
Int Arch Allergy Immunol; 1993; 101(3):326-32. PubMed ID: 7686799
[TBL] [Abstract][Full Text] [Related]
28. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction.
Ying S; Kikuchi Y; Meng Q; Kay AB; Kaplan AP
J Allergy Clin Immunol; 2002 Apr; 109(4):694-700. PubMed ID: 11941321
[TBL] [Abstract][Full Text] [Related]
29. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction.
Charlesworth EN; Kagey-Sobotka A; Norman PS; Lichtenstein LM
J Allergy Clin Immunol; 1989 May; 83(5):905-12. PubMed ID: 2469708
[TBL] [Abstract][Full Text] [Related]
30. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment.
Bascom R; Wachs M; Naclerio RM; Pipkorn U; Galli SJ; Lichtenstein LM
J Allergy Clin Immunol; 1988 Mar; 81(3):580-9. PubMed ID: 2450113
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandin D2 and histamine during the immediate and the late-phase components of allergic cutaneous responses.
Pienkowski MM; Adkinson NF; Plaut M; Norman PS; Lichtenstein LM
J Allergy Clin Immunol; 1988 Jul; 82(1):95-100. PubMed ID: 3292634
[TBL] [Abstract][Full Text] [Related]
32. The effect of salmeterol and salbutamol on mediator release and skin responses in immediate and late phase allergic cutaneous reactions.
Petersen LJ; Skov PS
Inflamm Res; 1999 Oct; 48(10):527-32. PubMed ID: 10563469
[TBL] [Abstract][Full Text] [Related]
33. Allergen induced histamine release and immunoreactive-leukotriene C4 generation from leukocytes in mite sensitive asthmatic patients.
Mita H; Yui Y; Yasueda H; Kajita T; Saito H; Shida T
Prostaglandins; 1986 May; 31(5):869-86. PubMed ID: 2425395
[TBL] [Abstract][Full Text] [Related]
34. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells.
Iliopoulos O; Proud D; Adkinson NF; Creticos PS; Norman PS; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
J Allergy Clin Immunol; 1991 Apr; 87(4):855-66. PubMed ID: 2013680
[TBL] [Abstract][Full Text] [Related]
35. Endogenous cortisol regulates immunoglobulin E-dependent late phase reactions.
Herrscher RF; Kasper C; Sullivan TJ
J Clin Invest; 1992 Aug; 90(2):596-603. PubMed ID: 1644926
[TBL] [Abstract][Full Text] [Related]
36. Inhibition by adenosine of histamine and leukotriene release from human basophils.
Peachell PT; Lichtenstein LM; Schleimer RP
Biochem Pharmacol; 1989 Jun; 38(11):1717-25. PubMed ID: 2472139
[TBL] [Abstract][Full Text] [Related]
37. Patients with severe atopic dermatitis have activated circulating basophils.
James JM; Kagey-Sobotka A; Sampson HA
J Allergy Clin Immunol; 1993 Jun; 91(6):1155-62. PubMed ID: 7685363
[TBL] [Abstract][Full Text] [Related]
38. Dose-response studies of the suppression of whole blood histamine and basophil counts by prednisone.
Saavedra-Delgado AM; Mathews KP; Pan PM; Kay DR; Muilenberg ML
J Allergy Clin Immunol; 1980 Dec; 66(6):464-71. PubMed ID: 7430504
[TBL] [Abstract][Full Text] [Related]
39. Mast cells, tissue histamine and eosinophils in early- and late-phase skin reactions: effects of a single dose of prednisolone.
Hammarlund A; Pipkorn U; Enerbäck L
Int Arch Allergy Appl Immunol; 1990; 93(2-3):171-7. PubMed ID: 2099342
[TBL] [Abstract][Full Text] [Related]
40. Histamine suppression of in vivo eosinophil accumulation and histamine release in human allergic reactions.
Ting S; Zweiman B; Lavker R; Dunsky EH
J Allergy Clin Immunol; 1981 Jul; 68(1):65-71. PubMed ID: 6165750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
